US Broker Ratings

Moderna, Inc. (MRNA) Stock Analysis: Unveiling a 48% Upside Potential Amidst Industry Challenges

In the fast-evolving biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) stands as a noteworthy player, particularly recognized for its pioneering messenger RNA (mRNA) medicines. Headquartered in Cambridge,..

Novartis AG (NVS) Stock Analysis: A Healthcare Giant with a 3.23% Dividend Yield and Strong Revenue Growth

Novartis AG (NYSE: NVS), a leading player in the global healthcare sector, has long been a staple for investors seeking exposure to the drug manufacturing industry...

Exelixis, Inc. (EXEL) Investor Outlook: A Biotech Powerhouse with a 13.51% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL), a pioneering force in oncology, continues to capture the attention of investors with its focus on developing innovative treatments for challenging cancers...

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking the 10% Potential Upside with Strong Buy Ratings

For investors eyeing the dynamic intersection of technology and healthcare, Veeva Systems Inc. (NYSE: VEEV) presents a compelling opportunity. With a robust market capitalization of $47.73..

Dr. Reddy’s Laboratories Ltd (RDY): Investor Outlook on Growth Potential and Analyst Consensus

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a stalwart in the healthcare sector, remains a focal point for investors due to its robust position in the specialty..

Ascendis Pharma A/S (ASND) Stock Analysis: A 23.69% Upside Powered by Robust Revenue Growth

For investors seeking exposure to the dynamic biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents a compelling opportunity. With a market capitalization of $12.21 billion and..

HealthEquity, Inc. (HQY): Analyst Consensus Reveals 28.76% Potential Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the health information services industry, has been catching the eye of investors with its robust growth prospects and..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Unveiling a 36.67% Upside Potential

Investors eyeing the healthcare sector might find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) an intriguing prospect, particularly given its robust potential for growth. With a market capitalization..

United Therapeutics Corporation (UTHR) Stock Analysis: Strong Buy Ratings and 14.82% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, particularly within the drug manufacturers’ industry specializing in both specialty and generic drugs. With a..

DaVita Inc. (DVA) Stock Report: Examining the 21% Potential Upside for Investors

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector, specifically within the medical care facilities industry, has garnered attention with its robust potential for..

argenx SE (ARGX) Stock Analysis: Exploring the 12.12% Potential Upside in Biotech Innovation

argenx SE (NASDAQ: ARGX), a dynamic player in the biotechnology sector, continues to capture investor attention with its promising pipeline and significant market presence. As a..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 7.74% Potential Upside for Investors

Doximity, Inc. (NYSE: DOCS) has positioned itself as a formidable player within the healthcare sector, specializing in health information services. With a market capitalization of $12.36..

ResMed Inc. (RMD) Stock Analysis: Unveiling an 18.87% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a titan in the healthcare sector specializing in medical instruments and supplies, presents an intriguing prospect for investors seeking growth in the..

Genmab A/S (GMAB) Stock Analysis: Evaluating a Promising 31.47% Upside in Biotechnology

Genmab A/S (NASDAQ: GMAB), a Danish biotechnology powerhouse, has captured the attention of investors with its robust pipeline of antibody-based products targeting cancer and other diseases...

Chemed Corp (CHE) Stock Analysis: Healthcare Giant with a Promising 34% Upside Potential

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, is making waves in the investment community with its compelling growth potential and robust operational..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating Healthcare Prospects with a 21.98% Potential Upside

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to medical devices and health technology. Based..

Takeda Pharmaceutical (TAK) Stock Analysis: Unpacking a Potential 31.94% Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust portfolio and strategic collaborations...

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 21% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a dominant player in the healthcare sector, is known for its extensive portfolio of generic medicines and biopharmaceutical products. Based in..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

Universal Health Services, Inc. (UHS) Stock Analysis: Insights into a Potential 11.73% Upside

Universal Health Services, Inc. (UHS), a prominent player in the healthcare sector, stands out with its diversified portfolio of acute care hospitals, outpatient facilities, and behavioral..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds